Department of Anesthesiology, Pain Research Center, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Pain. 2022 Jan 1;163(1):e106-e120. doi: 10.1097/j.pain.0000000000002321.
Peripheral nerve regeneration is associated with pain in several preclinical models of neuropathic pain. Some neuropathic pain conditions and preclinical neuropathic pain behaviors are improved by sympathetic blockade. In this study, we examined the effect of a localized "microsympathectomy," ie, cutting the gray rami containing sympathetic postganglionic axons where they enter the L4 and L5 spinal nerves, which is more analogous to clinically used sympathetic blockade compared with chemical or surgical sympathectomy. We also examined manipulations of CCL2 (monocyte chemoattractant protein 1), a key player in both regeneration and pain. We used rat tibial nerve crush as a neuropathic pain model in which peripheral nerve regeneration can occur successfully. CCL2 in the sensory ganglia was increased by tibial nerve crush and reduced by microsympathectomy. Microsympathectomy and localized siRNA-mediated knockdown of CCL2 in the lumbar dorsal root ganglion had very similar effects: partial improvement of mechanical hypersensitivity and guarding behavior, reduction of regeneration markers growth-associated protein 43 and activating transcription factor 3, and reduction of macrophage density in the sensory ganglia and regenerating nerve. Microsympathectomy reduced functional regeneration as measured by myelinated action potential propagation through the injury site and denervation-induced atrophy of the tibial-innervated gastrocnemius muscle at day 10. Microsympathectomy plus CCL2 knockdown had behavioral effects similar to microsympathectomy alone. The results show that local sympathetic effects on neuropathic pain may be mediated in a large part by the effects on expression of CCL2, which in turn regulates the regeneration process.
周围神经再生与几种神经性疼痛的临床前模型中的疼痛有关。一些神经性疼痛状况和临床前神经性疼痛行为通过交感神经阻断得到改善。在这项研究中,我们检查了局部“ microsympathectomy”(即切断包含进入 L4 和 L5 脊神经的交感节后轴突的灰色神经节)的效果,与化学或手术交感神经切除术相比,这种方法与临床上使用的交感神经阻断更相似。我们还检查了 CCL2(单核细胞趋化蛋白 1)的操作,CCL2 是再生和疼痛的关键参与者。我们使用大鼠胫骨神经挤压作为神经性疼痛模型,其中可以成功发生周围神经再生。胫骨神经挤压会增加感觉神经节中的 CCL2,并通过 microsympathectomy 减少。 microsympathectomy 和局部 siRNA 介导的腰椎背根神经节中 CCL2 的敲低具有非常相似的效果:机械性超敏反应和保护行为部分改善,生长相关蛋白 43 和激活转录因子 3 的再生标志物减少,以及感觉神经节和再生神经中的巨噬细胞密度减少。 microsympathectomy 通过损伤部位髓鞘动作电位的传播和失神经支配诱导的胫骨支配的比目鱼肌萎缩来减少功能再生,在第 10 天。 microsympathectomy 加 CCL2 敲低具有与 microsympathectomy 单独相似的行为效果。结果表明,局部交感神经对神经性疼痛的影响可能在很大程度上是通过对 CCL2 表达的影响介导的,CCL2 反过来又调节再生过程。